Corrigendum to “ESPEN guideline: Clinical nutrition in inflammatory bowel disease” (Clinical Nutrition (2017) 36(2) (321–347), (S0261561416313681), (10.1016/j.clnu.2016.12.027))

Alastair Forbes, Johanna Escher, Xavier H_ebuterne, Stanisław Kłe˛k, Zeljko Krznaric, St_ephane Schneider, Raanan Shamir, Kalina Stardelova, Nicolette Wierdsma, Anthony E. Wiskin, Stephan C. Bischoff

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3 ® ”, refer only to the product used in the cited literature and equivalent products independent from the present product labelings. This product is now known by the generic name “De Simone Formulation”. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Number of pages1
JournalClinical Nutrition
Volume38
Issue number3
DOIs
Publication statusPublished - 1 Jun 2019

Cite this

Forbes, Alastair ; Escher, Johanna ; H_ebuterne, Xavier ; Kłe˛k, Stanisław ; Krznaric, Zeljko ; Schneider, St_ephane ; Shamir, Raanan ; Stardelova, Kalina ; Wierdsma, Nicolette ; Wiskin, Anthony E. ; Bischoff, Stephan C. / Corrigendum to “ESPEN guideline : Clinical nutrition in inflammatory bowel disease” (Clinical Nutrition (2017) 36(2) (321–347), (S0261561416313681), (10.1016/j.clnu.2016.12.027)). In: Clinical Nutrition. 2019 ; Vol. 38, No. 3.
@article{e459419181ba4bcf8160ad3463f9b261,
title = "Corrigendum to “ESPEN guideline: Clinical nutrition in inflammatory bowel disease” (Clinical Nutrition (2017) 36(2) (321–347), (S0261561416313681), (10.1016/j.clnu.2016.12.027))",
abstract = "The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3 {\circledR} ”, refer only to the product used in the cited literature and equivalent products independent from the present product labelings. This product is now known by the generic name “De Simone Formulation”. The authors would like to apologise for any inconvenience caused.",
author = "Alastair Forbes and Johanna Escher and Xavier H_ebuterne and Stanisław Kłe˛k and Zeljko Krznaric and St_ephane Schneider and Raanan Shamir and Kalina Stardelova and Nicolette Wierdsma and Wiskin, {Anthony E.} and Bischoff, {Stephan C.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.clnu.2019.01.017",
language = "English",
volume = "38",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Churchill Livingstone",
number = "3",

}

Corrigendum to “ESPEN guideline : Clinical nutrition in inflammatory bowel disease” (Clinical Nutrition (2017) 36(2) (321–347), (S0261561416313681), (10.1016/j.clnu.2016.12.027)). / Forbes, Alastair; Escher, Johanna; H_ebuterne, Xavier; Kłe˛k, Stanisław; Krznaric, Zeljko; Schneider, St_ephane; Shamir, Raanan; Stardelova, Kalina; Wierdsma, Nicolette; Wiskin, Anthony E.; Bischoff, Stephan C.

In: Clinical Nutrition, Vol. 38, No. 3, 01.06.2019.

Research output: Contribution to journalComment/Letter to the editorAcademic

TY - JOUR

T1 - Corrigendum to “ESPEN guideline

T2 - Clinical nutrition in inflammatory bowel disease” (Clinical Nutrition (2017) 36(2) (321–347), (S0261561416313681), (10.1016/j.clnu.2016.12.027))

AU - Forbes, Alastair

AU - Escher, Johanna

AU - H_ebuterne, Xavier

AU - Kłe˛k, Stanisław

AU - Krznaric, Zeljko

AU - Schneider, St_ephane

AU - Shamir, Raanan

AU - Stardelova, Kalina

AU - Wierdsma, Nicolette

AU - Wiskin, Anthony E.

AU - Bischoff, Stephan C.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3 ® ”, refer only to the product used in the cited literature and equivalent products independent from the present product labelings. This product is now known by the generic name “De Simone Formulation”. The authors would like to apologise for any inconvenience caused.

AB - The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3 ® ”, refer only to the product used in the cited literature and equivalent products independent from the present product labelings. This product is now known by the generic name “De Simone Formulation”. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063759309&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30955984

U2 - 10.1016/j.clnu.2019.01.017

DO - 10.1016/j.clnu.2019.01.017

M3 - Comment/Letter to the editor

VL - 38

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

IS - 3

ER -